Global Longlife Hospital and Research Ltd

Asahi Enterprise Limited (formerly Global Longlife Hospital and Research Limited) has announced its first Extra Ordinary General Meeting (EGM) for FY 2026-2027. The meeting is scheduled for Friday, October 30, 2026, at 12:15 PM IST and will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The primary agenda item is the ratification of the submission of a Practicing Chartered Accountant's Certificate concerning the company's name change from Global Longlife Hospital and Research Limited to Asahi Enterprise Limited, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice has been sent electronically to members and is also available on the company's website.

Global Longlife Hospital and Research Ltd (now Asahi Enterprise Limited) announced that its Board of Directors has approved convening the First Extra-Ordinary General Meeting (EGM) for FY 2026-2027 on Friday, October 30, 2026. The EGM will be held via video conferencing to seek shareholder approval for an aforementioned issuance. The Board also adopted the Notice of the EGM and authorized its issuance. M/s Insiya Nalawala & Associates has been appointed as the scrutinizer, and National Securities Depository Limited (NSDL) as the remote e-voting agency. The meeting commenced at 02:15 P.M. and concluded at 03:30 PM.

Global Longlife Hospital and Research Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut for all insiders, including designated persons, effective from October 1, 2026. It will remain closed until 48 hours after the declaration of the company's un-audited financial results for the half-year ended September 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

Global Longlife Hospital and Research Limited has officially changed its name to Asahi Enterprise Limited. The company received approval from the Registrar of Companies (ROC) on September 25, 2026, for the alteration. The Certificate of Incorporation reflecting the new name was issued on September 28, 2026. The change is effective from September 25, 2026. The company is required to display its old name alongside the new name for two years. This rebranding is a significant corporate action, and stakeholders are advised to update their records.

Abhishek Ashvinbhai Kamdar HUF has acquired 5,35,000 shares, representing 5.09% of the total share capital, in Global Longlife Hospital and Research Ltd through open market transactions. The acquisition took place on September 25, 2026. Following this transaction, Abhishek Ashvinbhai Kamdar HUF holds 5,35,000 shares, also representing 5.09% of the total diluted share capital. The total equity share capital of the company remains 1,05,00,000 shares.

Global Longlife Hospital and Research Ltd has received approval from the Ministry of Corporate Affairs (MCA) for the alteration of its Memorandum of Association (MOA) object clause. This change, effective August 25, 2026, expands the company's business scope to include a wide range of activities in food products, agricultural commodities, textiles, apparels, and dealing in commodity exchanges and bullion markets. The alteration was approved by shareholders and filed with the Registrar of Companies.

Trade Pulse Broking Pvt Ltd has disclosed an increase in its shareholding in Global Longlife Hospital and Research Ltd. The acquisition, executed via the open market on August 7, 2026, has raised Trade Pulse Broking's stake from 4.76% to 7.31%. This move signifies a growing interest from the broking firm in the hospital and research sector.

Dhruv Jani has disclosed the sale of 7,22,000 equity shares, representing 6.88% of the total share capital, in Global Longlife Hospital and Research Limited. The transaction, conducted via the open market, occurred between August 10 and August 12, 2026. Following the sale, Jani's holding in the company has reduced to 990 shares, or 0.01% of the total share capital. The total diluted share capital of the company after the sale is not applicable. The total value of the shares before the sale was Rs. 10,50,00,000/- (1,05,00,000 Equity Shares of Rs. 10/- each).

Dhruv Sureshkumar Jani has disclosed the sale of 10,00,000 equity shares, representing 9.52% of the total share capital, in Global Longlife Hospital and Research Limited. The transaction, conducted via the open market between August 6-7, 2026, reduced Jani's holding from 16.41% to 6.89%. The total value of the sale is approximately ₹10.50 crore. This disclosure is made under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011.

Dhruv Jani has disclosed the sale of 6,78,000 equity shares, representing 6.46% of the total share capital, in Global Longlife Hospital and Research Limited. The transaction occurred through the open market between July 1 and July 30, 2026. Following the sale, Jani's holding in the company has reduced from 22.87% to 16.41%. The total equity share capital of the company before and after the sale remains Rs. 10,50,00,000/-.